ATE288924T1 - Tnf inhibierendes protein tip-b1 und dessen verwendung - Google Patents

Tnf inhibierendes protein tip-b1 und dessen verwendung

Info

Publication number
ATE288924T1
ATE288924T1 AT98123140T AT98123140T ATE288924T1 AT E288924 T1 ATE288924 T1 AT E288924T1 AT 98123140 T AT98123140 T AT 98123140T AT 98123140 T AT98123140 T AT 98123140T AT E288924 T1 ATE288924 T1 AT E288924T1
Authority
AT
Austria
Prior art keywords
tnf
protein
cell
tip
sequences
Prior art date
Application number
AT98123140T
Other languages
English (en)
Inventor
Erica Berleth
Jane M Ehrke
Srikanth Nadadur
Hira Gurtoo
Alicia Henn
Enrico Mihich
Original Assignee
Health Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Health Research Inc filed Critical Health Research Inc
Application granted granted Critical
Publication of ATE288924T1 publication Critical patent/ATE288924T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98123140T 1998-09-21 1998-12-04 Tnf inhibierendes protein tip-b1 und dessen verwendung ATE288924T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/157,910 US6197744B1 (en) 1998-09-21 1998-09-21 Tumor necrosis factor inhibitory protein tip B1 and method of using same

Publications (1)

Publication Number Publication Date
ATE288924T1 true ATE288924T1 (de) 2005-02-15

Family

ID=22565843

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98123140T ATE288924T1 (de) 1998-09-21 1998-12-04 Tnf inhibierendes protein tip-b1 und dessen verwendung

Country Status (4)

Country Link
US (1) US6197744B1 (de)
EP (1) EP0997475B1 (de)
AT (1) ATE288924T1 (de)
DE (1) DE69828972T2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000232886A (ja) * 1999-02-16 2000-08-29 Jcr Pharmaceuticals Co Ltd 成長ホルモン依存性遺伝子

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL83878A (en) 1987-09-13 1995-07-31 Yeda Res & Dev Soluble protein corresponding to tnf inhibitory protein its preparation and pharmaceutical compositions containing it
US5136021A (en) * 1990-02-27 1992-08-04 Health Research, Inc. TNF-inhibitory protein and a method of production

Also Published As

Publication number Publication date
DE69828972T2 (de) 2006-01-19
US6197744B1 (en) 2001-03-06
EP0997475A1 (de) 2000-05-03
EP0997475B1 (de) 2005-02-09
DE69828972D1 (de) 2005-03-17

Similar Documents

Publication Publication Date Title
DE69725293D1 (de) N-(2 oxoacetyl oder sulphonyl)-pyrrolidine/piperidine-2-carbonsäurederivate mit verbesserter multi-drug resistenz aktivität
BR9408025A (pt) Compostos de peptidila e seu uso terapêutico como inibidores de metaloproteinases
ATE221881T1 (de) Tetralin-verbindungen mit multi-drugresistenz (mdr)-aktivitat
IS4073A (is) Nýtt fjölvirknislyf gegn aukningu mótstöðu
TR199802421T2 (xx) Doku yenilenmesini d�zenleyen maddeler.
NO326660B1 (no) Imidazolyl-cykliske acetal forbindelser, farmasøytiske sammensetninger inneholdende disse forbindelser og anvendelse av forbindelsene
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
ATE317848T1 (de) Unterbrochene 2'-modifizierte oligonukleotide
DK0633721T3 (da) Rensning af blodplader med 8-metoxypsoralen
EP0957926A4 (de) Oligonucleotidzusammenstellung und verfahren zur regulierung der protein b7 expression
DE69519997D1 (de) Verwendung von bindungsreagenzien gegen cd23 in der behandlung von autoimmunkrankheiten
ATE476495T1 (de) Bazillus thuringiensis und dessen insektizide proteine
ATE237682T1 (de) Universale spenderzellen
ATE268385T1 (de) Mykrobakterielle proteine, mikroorganismen welche diese produzieren und ihre verwendung als impfstoff und zum nachweis von zuberkulose
DE3876400D1 (de) Aminosaeure-imid-derivate, ihre verwendung und diese enthaltende medizinische zusammensetzungen.
PT1017408E (pt) Utilizacao de tetra-hidrolipstatina no tratamento de diabetes de tipo ii
DK0877803T3 (da) OB-proteinreceptor og relaterede sammensætninger og fremgangsmåder
ATE277171T1 (de) Ikk-alpha proteine, nukleinsäuren und verfahren
ATE245190T1 (de) Robo: eine familie polypeptiden und nukleinesäuren wirksam in nervenzellleitung
PT1007559E (pt) Celulas geneticamente modificadas que expressam as proteinas morfogeneticas do osso
DE50009113D1 (de) Gegen ccr5 gerichtete antikörperkonstrukte und ihre verwendung in der behandlung von autoimmunkrankheiten
ATE205600T1 (de) Leukozytadhaesiontest
ATE288924T1 (de) Tnf inhibierendes protein tip-b1 und dessen verwendung
ATE291586T1 (de) Humanes antibiotisches protein
ATE291621T1 (de) Nukleinsaeuren und proteine der katze fc-epsilon rezeptor alpha-kette und deren verwendungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties